Consistent with our findings, work by van Rhenen and colleagues showed that anti-CLL-1 mAbs did not influence engraftment of AML CD34+ cells in NOD/SCID mice [7]. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.